These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6985)

  • 1. Exposure in vivo of agoraphobics: contributions of diazepam, group exposure, and anxiety evocation.
    Hafner J; Marks I
    Psychol Med; 1976 Feb; 6(1):71-88. PubMed ID: 6985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imipramine and brief therapists-aided exposure in agoraphobics having self-exposure homework.
    Marks IM; Gray S; Cohen D; Hill R; Mawson D; Ramm E; Stern RS
    Arch Gen Psychiatry; 1983 Feb; 40(2):153-62. PubMed ID: 6130752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fresh symptom emergence after intensive behaviour therapy.
    Hafner RJ
    Br J Psychiatry; 1976 Oct; 129():378-83. PubMed ID: 10038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agoraphobics 5 years after imipramine and exposure. Outcome and predictors.
    Lelliott PT; Marks IM; Monteiro WO; Tsakiris F; Noshirvani H
    J Nerv Ment Dis; 1987 Oct; 175(10):599-605. PubMed ID: 3309186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaginal flooding and exposure to real phobic situations: treatment outcome with agoraphobic patients.
    Mathews AM; Johnston DW; Lancashire M; Munby M; Shaw PM; Gelder MG
    Br J Psychiatry; 1976 Oct; 129():361-71. PubMed ID: 10036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-year follow-up of agoraphobics after exposure and imipramine.
    Cohen SD; Monteiro W; Marks IM
    Br J Psychiatry; 1984 Mar; 144():276-81. PubMed ID: 6367875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of concurrent diazepam treatment on the outcome of exposure therapy in agoraphobia.
    Wardle J; Hayward P; Higgitt A; Stabl M; Blizard R; Gray J
    Behav Res Ther; 1994 Feb; 32(2):203-15. PubMed ID: 7908800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive modification versus prolonged exposure in vivo: a comparison with agoraphobics as subjects.
    Emmelkamp PM; Kuipers AC; Eggeraat JB
    Behav Res Ther; 1978; 16(1):33-41. PubMed ID: 27165
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative studies on benzodiazepines and psychotherapies.
    Marks I
    Encephale; 1983; 9(4 Suppl 2):23B-30B. PubMed ID: 6202493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generalization of therapeutic changes in agoraphobia: the role of perceived self-efficacy.
    Williams SL; Kinney PJ; Falbo J
    J Consult Clin Psychol; 1989 Jun; 57(3):436-42. PubMed ID: 2567745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavior therapy, supportive psychotherapy, imipramine, and phobias.
    Zitrin CM; Klein DF; Woerner MG
    Arch Gen Psychiatry; 1978 Mar; 35(3):307-16. PubMed ID: 31847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is agoraphobia harder to treat? A comparison of agoraphobics' and simple phobics' response to treatment.
    Chambless DL; Woody SR
    Behav Res Ther; 1990; 28(4):305-12. PubMed ID: 1977381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follow-up of agoraphobic patients treated with exposure in vivo or applied relaxation.
    Jansson L; Jerremalm A; Ost LG
    Br J Psychiatry; 1986 Oct; 149():486-90. PubMed ID: 2880629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synchrony and desynchrony in high and low arousal subjects undergoing therapeutic exposure.
    Gerew AB; Romney DM; Leboeuf A
    J Behav Ther Exp Psychiatry; 1989 Mar; 20(1):41-8. PubMed ID: 2570083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agoraphobia: relative and combined effectiveness of therapist-assisted in vivo exposure and imipramine.
    Mavissakalian M; Michelson L
    J Clin Psychiatry; 1986 Mar; 47(3):117-22. PubMed ID: 3512534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Declining-dose drug desensitization for phobias. Clinical and psychophysiological studies.
    McCormick WO
    Can Psychiatr Assoc J; 1973 Feb; 18(1):33-40. PubMed ID: 4693076
    [No Abstract]   [Full Text] [Related]  

  • 17. Alprazolam and exposure alone and combined in panic disorder with agoraphobia. A controlled study in London and Toronto.
    Marks IM; Swinson RP; Başoğlu M; Kuch K; Noshirvani H; O'Sullivan G; Lelliott PT; Kirby M; McNamee G; Sengun S
    Br J Psychiatry; 1993 Jun; 162():776-87. PubMed ID: 8101126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptomatic treatment of agoraphobia and social phobias: a follow-up study.
    Tyrer P; Steinberg D
    Br J Psychiatry; 1975 Aug; 127():163-8. PubMed ID: 241454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relative efficacy of imaginal and in vivo desensitization in the treatment of agoraphobia.
    James JE; Hampton BA; Larsen SA
    J Behav Ther Exp Psychiatry; 1983 Sep; 14(3):203-7. PubMed ID: 6139389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Measurement of skin conductivity as anxiety monitor in systematical desensitization of phobias (author's transl)].
    Sorgatz G; Sorgatz H
    Psychother Med Psychol (Stuttg); 1977 Jul; 27(4):143-7. PubMed ID: 19809
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.